These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 11031966
1. [Paraneoplastic retinal degeneration, cancer-associated retinopathy]. Kuriyama M, Fujii A, Yoneda M. Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):347-50. PubMed ID: 11031966 [No Abstract] [Full Text] [Related]
5. Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Adamus G, Guy J, Schmied JL, Arendt A, Hargrave PA. Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357 [Abstract] [Full Text] [Related]
6. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy. Ohguro H, Ogawa K, Nakagawa T. Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430 [Abstract] [Full Text] [Related]
7. [Carcinoma-associated retinopathy: a review with clinical examples]. Sobottka B, Schlote T, Besch D, Djelebova T, Wilhelm H, Zrenner E. Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938 [Abstract] [Full Text] [Related]
11. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. Ohguro H, Ogawa K, Maeda T, Maeda A, Maruyama I. Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938 [Abstract] [Full Text] [Related]
12. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines. Maeda A, Ohguro H, Maeda T, Wada I, Sato N, Kuroki Y, Nakagawa T. Cancer Res; 2000 Apr 01; 60(7):1914-20. PubMed ID: 10766180 [Abstract] [Full Text] [Related]
13. [Paraneoplastic neurologic syndrome--neoplasms and neuroimmune system]. Inuzuka T, Tanaka K. Nihon Naika Gakkai Zasshi; 1998 Jun 10; 87(6):1138-43. PubMed ID: 9702029 [No Abstract] [Full Text] [Related]
14. Fluorescein angiographic findings in a case of cancer-associated retinopathy. Masaoka N, Emoto Y, Sasaoka A, Fukushima A, Ueno H, Ohguro H. Retina; 1999 Jun 10; 19(5):462-4. PubMed ID: 10546949 [No Abstract] [Full Text] [Related]
15. Clinical and immunologic aspects of cancer-associated retinopathy. Ohguro H, Yokoi Y, Ohguro I, Mamiya K, Ishikawa F, Yamazaki H, Metoki T, Takano Y, Ito T, Nakazawa M. Am J Ophthalmol; 2004 Jun 10; 137(6):1117-9. PubMed ID: 15183799 [Abstract] [Full Text] [Related]
18. Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity. Matsubara S, Yamaji Y, Fujita T, Kanayama T, Yamadori I, Sato M, Fujita J, Shiotani T, Takahara J. Lung Cancer; 1996 Jun 10; 14(2-3):265-71. PubMed ID: 8794409 [Abstract] [Full Text] [Related]
20. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation. Ohguro H, Ogawa K, Maeda T, Maruyama I, Maeda A, Takano Y, Nakazawa M. Invest Ophthalmol Vis Sci; 2001 Oct 10; 42(11):2589-95. PubMed ID: 11581204 [Abstract] [Full Text] [Related] Page: [Next] [New Search]